SYK

SELL

Stryker Corporation

Healthcare · Rank #157 · Analyzed Oct 18, 2026

$294.66

Current Price

$237.75

Intrinsic Value

-19.3%

Upside/Downside

3.5/10

Score

3.5/5

Quality

Analysis Summary

Valuation Consensus0/2 methods agree

Quality Score3.5/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 19.3%

Fair Value Range

Low$85.79

Base (IV)$237.75

High$335.20

Entry Points

Conservative$60.05

Moderate$85.79

Aggressive$166.43

Quality & Moat Breakdown

Return on Equity16.5% → 1.0/1.0

Debt LevelD/E 64 → 0/1.0

Revenue QualityGrowth 11.2%, margin Δ+0.2% +recovery → 1.0/1.0

Moat Strength3.5/5 → 0.5/1.0

Profit Margins14.4% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.